Join
Live feed
·
INSIDERFilingvia Quantisnow
Nektar Therapeutics logo

SEC Form 4: Chess Robert sold $6,834 worth of shares (10,200 units at $0.67), decreasing direct ownership by 4% to 274,773 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NKTR (Nektar Therapeutics) and more on Quantisnow.